Newsfeed : Fraud Schemes for HIV Meds Cost Medicare $33M

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Newsfeed » August 2014

Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

20 Years Ago In POZ


More News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to news@poz.com.


emailprint

August 8, 2014

Fraud Schemes for HIV Meds Cost Medicare $33M

A new report from the U.S. Department of Health and Human Services (HHS) has uncovered that Medicare spent more than $30 million on suspicious claims for HIV medications in 2012, most likely as a result of fraud schemes conducted under the agency’s Part D prescription drug program.

The wide array of drug-money heists was reviewed in an article co-published by ProPublica and The Washington Post. Turns out, more than half of these instances involved patients with no record of HIV filling tens-of-thousands of dollars worth of prescriptions for antiretrovirals.

The HHS suspects that these bogus patients sold the HIV drugs on the black market, or that pharmacies across the country billed for meds that beneficiaries never received. In another scheme, thieves stole beneficiaries’ ID numbers and used them to buy expensive drugs without their knowledge.

The new report raises big questions about Medicare’s lax oversight of HIV prescription drugs. It argues that the agency has inadvertently enabled doctors to prescribe huge quantities of potentially unnecessary medications, that it has wasted billions of dollars on needlessly pricey treatments and that it has also exposed the program to rampant fraud schemes.

To combat this abuse, the agency’s inspector general is now recommending that the Centers for Medicare and Medicaid Services (CMS) use prescription data to look for suspicious behavior among its patients. HHS is also encouraging CMS to expand its controls over HIV meds and to restrict its beneficiaries to a limited number of pharmacies and prescribers.

Now, it’s up to Congress to take steps to implement these fraud-prevention plans.

To read the ProPublica/WaPo article, click here.

To read the HHS report, click here.

Search: Medicare, fraud, HIV medication, HHS, suspicious claims, Part D, prescription drugs, CMS


Scroll down to comment on this story.



Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules



Show comments (1 total)

 
[Go to top]

Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar
POZ on Twitter

Ask POZ Pharmacist

Talk to Us
Poll
Are you buying holiday gifts that raise HIV/AIDS awareness?
Yes
No

Survey
Smoke Signals

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.